Carisma Therapeutics, Inc. (CARM)
USD 0.46
(-1.62%)
USD 0.46
(-1.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 14.91 Million | 9.83 Million | 26.54 Million | 11.23 Million | - | - |
| Cost of Revenue | 74.12 Million | 6.09 Million | 85 Thousand | - | 219 Thousand | 208 Thousand |
| Gross Profit | -59.2 Million | 3.74 Million | 26.45 Million | 11.23 Million | -219 Thousand | -208 Thousand |
| Operating Expenses | 103.65 Million | 59.9 Million | 40.79 Million | 28.37 Million | 36.65 Million | 25.49 Million |
| Selling, General and Administrative Expenses | 29.52 Million | 3.28 Million | 6.4 Million | 5.08 Million | 12.2 Million | 11.62 Million |
| Research and Development Expenses | 74.12 Million | 56.61 Million | 34.38 Million | 23.29 Million | 24.44 Million | 13.86 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 103.65 Million | 65.99 Million | 40.79 Million | 28.37 Million | 36.87 Million | 25.7 Million |
| Operating Income | -88.73 Million | -56.16 Million | -40.79 Million | -28.37 Million | -36.87 Million | -25.7 Million |
| Interest Expense | - | 3.14 Million | - | - | - | - |
| Income Tax Expense | - | -3.87 Million | -10 Thousand | -29 Thousand | - | 46.85 Thousand |
| Earnings before Tax | -86.87 Million | -61.22 Million | -40.78 Million | -28.34 Million | -107.5 Million | -33.69 Million |
| Net Income | -86.87 Million | -61.22 Million | -40.77 Million | -28.32 Million | -107.5 Million | -33.69 Million |
| Earnings Per Share Basic | -2.59 | -575.42 | -4.47 | -4.79 | -23.64 | -10.91 |
| Earnings Per Share Diluted | -2.59 | -575.42 | -4.47 | -4.79 | -23.64 | -10.91 |
| Weighted Average Shares Outstanding | 33.52 Million | 106.4 Thousand | 9.11 Million | 5.91 Million | 4.54 Million | 3.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.52 Million | 106.4 Thousand | 9.11 Million | 5.91 Million | 4.54 Million | 3.08 Million |
| Gross Margin | -3.97 | 0.38 | 1.00 | 1.00 | - | - |
| EBIT Margin | -5.76 | -5.09 | -1.51 | -2.49 | - | - |
| Profit Margin | -5.82 | -6.23 | -1.54 | -2.52 | - | - |
| EBITDA | -85.89 Million | -51.99 Million | -40.11 Million | -27.93 Million | -107.28 Million | -33.48 Million |
| Earnings Before Tax Margin | -5.95 | -5.71 | -1.54 | -2.53 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 9.19 Million | 3.39 Million | 4.28 Million | 14.91 Million | 3.82 Million | 3.56 Million |
| Cost of Revenue | 255 Thousand | 1.69 Million | 2.08 Million | 8.26 Million | 695 Thousand | 715 Thousand |
| Gross Profit | 8.94 Million | 1.7 Million | 2.2 Million | 6.65 Million | 3.13 Million | 2.84 Million |
| Operating Expenses | 20.61 Million | 21.21 Million | 24.65 Million | 95.38 Million | 26.17 Million | 24.52 Million |
| Selling, General and Administrative Expenses | 5.3 Million | 3.75 Million | 5.24 Million | - | 6.62 Million | 6 Million |
| Research and Development Expenses | 15.3 Million | 17.46 Million | 19.41 Million | - | 19.55 Million | 18.51 Million |
| Other Expenses | -15.3 Million | - | - | - | - | - |
| Cost and Expenses | 20.86 Million | 22.9 Million | 26.73 Million | 103.65 Million | 26.17 Million | 24.52 Million |
| Operating Income | -11.67 Million | -19.51 Million | -22.45 Million | -88.73 Million | -22.34 Million | -20.96 Million |
| Interest Expense | 508 Thousand | 532 Thousand | 291 Thousand | 1.93 Million | - | - |
| Income Tax Expense | - | 1.64 Million | -197 Thousand | 8.09 Million | -695 Thousand | 88 Thousand |
| Earnings before Tax | -11.16 Million | -18.97 Million | -21.15 Million | -86.87 Million | -21.4 Million | -19.78 Million |
| Net Income | -11.16 Million | -18.97 Million | -20.95 Million | -86.87 Million | -21.4 Million | -19.87 Million |
| Earnings Per Share Basic | -0.27 | -0.46 | -0.52 | - | -0.53 | -0.49 |
| Earnings Per Share Diluted | -0.27 | -0.46 | -0.52 | - | -0.53 | -0.49 |
| Weighted Average Shares Outstanding | 41.54 Million | 40.93 Million | 40.39 Million | 33.52 Million | 40.28 Million | 40.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.54 Million | 40.93 Million | 40.39 Million | 33.52 Million | 40.28 Million | 40.25 Million |
| Gross Margin | 0.97 | 0.50 | 0.51 | 0.45 | 0.82 | 0.80 |
| EBIT Margin | -1.24 | -5.24 | -4.75 | - | -5.84 | -5.89 |
| Profit Margin | -1.21 | -5.59 | -4.89 | -5.82 | -5.59 | -5.58 |
| EBITDA | -11.41 Million | -17.81 Million | -20.36 Million | - | -22.34 Million | -20.96 Million |
| Earnings Before Tax Margin | -1.27 | -5.74 | -5.23 | -5.95 | -5.84 | -5.89 |
SYBE
SELF
NTW
OLCLF
601933
MINT